MEN1 Gene Multiple Endocrine Neoplasia Type 1 NGS Genetic DNA Test
Comprehensive Genetic Screening for Hereditary Endocrine Disorders
The MEN1 Gene Multiple Endocrine Neoplasia Type 1 NGS Genetic DNA Test represents a breakthrough in preventive genetic medicine, offering individuals and families crucial insights into their hereditary risk for endocrine system disorders. Multiple Endocrine Neoplasia Type 1 (MEN1) is an autosomal dominant condition characterized by the development of tumors in multiple endocrine glands, primarily affecting the parathyroid glands, pancreatic islet cells, and anterior pituitary gland.
What This Advanced Genetic Test Detects
Our state-of-the-art NGS (Next-Generation Sequencing) technology meticulously analyzes the MEN1 gene located on chromosome 11q13. This comprehensive screening identifies:
- Pathogenic variants and mutations in the MEN1 tumor suppressor gene
- Germline mutations responsible for hereditary endocrine neoplasia syndromes
- Specific genetic alterations that predispose individuals to developing multiple endocrine tumors
- Inheritance patterns that can affect family members across generations
Who Should Consider MEN1 Genetic Testing?
This genetic screening is particularly recommended for individuals experiencing:
- Unexplained hypercalcemia or kidney stones suggesting hyperparathyroidism
- Recurrent peptic ulcers or severe abdominal pain indicating gastrinoma
- Hypoglycemic episodes potentially caused by insulinomas
- Visual field defects or hormonal imbalances suggesting pituitary tumors
- Family history of multiple endocrine tumors or MEN1 syndrome
- Early-onset endocrine disorders without clear cause
Significant Benefits of Early Detection
Undergoing MEN1 genetic testing provides numerous advantages for proactive health management:
- Early Intervention Opportunities: Identify at-risk individuals before symptom development
- Family Planning Guidance: Make informed decisions about genetic inheritance risks
- Personalized Surveillance: Implement targeted screening protocols for specific endocrine organs
- Treatment Optimization: Guide appropriate therapeutic approaches based on genetic profile
- Psychological Relief: Reduce uncertainty through definitive genetic information
Understanding Your Genetic Test Results
Our comprehensive genetic counseling services help you interpret your results effectively:
- Positive Result: Indicates presence of MEN1 gene mutation, requiring regular endocrine monitoring and family member testing
- Negative Result: Suggests absence of known MEN1 mutations, though continued clinical evaluation may be recommended
- Variant of Uncertain Significance: Requires additional family studies and ongoing research correlation
- Professional Guidance: All results include detailed consultation with genetic specialists
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Accessibility and Convenience
We maintain comprehensive testing facilities across the United States, with specialized centers in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible genetic testing services regardless of your location.
Take Control of Your Genetic Health Today
Don’t leave your endocrine health to chance. Our MEN1 Gene Multiple Endocrine Neoplasia Type 1 NGS Genetic DNA Test provides the clarity and confidence needed for proactive health management. With results available within 3-4 weeks and multiple sample collection options including blood, extracted DNA, or FTA card blood drops, getting tested has never been more convenient.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your comprehensive MEN1 genetic screening. Our dedicated genetic specialists are ready to guide you through every step of this important health journey.
